Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Natriuretic peptides.

× No keyword cloud information.

464 in total

Review 1. Vasopeptidase inhibition: a new direction in cardiovascular treatment.

Authors: J R Asher; A J Naftilan
Journal: Curr Hypertens Rep Date: 2000-08 Impact factor: 5.369

2. Circulating aldosterone and natriuretic peptides in the general community: relationship to cardiorenal and metabolic disease.

Authors: Alessia Buglioni; Valentina Cannone; Alessandro Cataliotti; S Jeson Sangaralingham; Denise M Heublein; Christopher G Scott; Kent R Bailey; Richard J Rodeheffer; Paolo Dessì-Fulgheri; Riccardo Sarzani; John C Burnett
Journal: Hypertension Date: 2014-11-03 Impact factor: 10.190

3. Atrial natriuretic factor increases splenic microvascular pressure and fluid extravasation in the rat.

Authors: R Sultanian; Y Deng; S Kaufman
Journal: J Physiol Date: 2001-05-15 Impact factor: 5.182

4. The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure.

Authors: Ahmet Fuat; Jeremy J Murphy; A Pali S Hungin; Jane Curry; Ali A Mehrzad; Andrew Hetherington; Jennifer I Johnston; W Stuart A Smellie; Victoria Duffy; Patricia Cawley
Journal: Br J Gen Pract Date: 2006-05 Impact factor: 5.386

5. N-terminal pro-brain natriuretic peptide and the timing, extent and mortality in ST elevation myocardial infarction.

Authors: Justin A Ezekowitz; Pierre Théroux; Weiching Chang; Kenneth W Mahaffey; Christopher B Granger; W D Weaver; Judith S Hochman; Paul W Armstrong
Journal: Can J Cardiol Date: 2006-04 Impact factor: 5.223

Review 6. B-type natriuretic peptide: spectrum of application. Nesiritide (recombinant BNP) for heart failure.

Authors: Gregg C Fonarow
Journal: Heart Fail Rev Date: 2003-10 Impact factor: 4.214

7. Phosphodiesterase 2A as a therapeutic target to restore cardiac neurotransmission during sympathetic hyperactivity.

Authors: Kun Liu; Dan Li; Guoliang Hao; David McCaffary; Oliver Neely; Lavinia Woodward; Demetris Ioannides; Chieh-Ju Lu; Marcella Brescia; Manuela Zaccolo; Harikrishna Tandri; Olujimi A Ajijola; Jeffrey L Ardell; Kalyanam Shivkumar; David J Paterson
Journal: JCI Insight Date: 2018-05-03

8. Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease.

Authors: J H Henriksen; J P Gøtze; S Fuglsang; E Christensen; F Bendtsen; S Møller
Journal: Gut Date: 2003-10 Impact factor: 23.059

9. Internalization and trafficking of guanylyl (guanylate) cyclase/natriuretic peptide receptor A is regulated by an acidic tyrosine-based cytoplasmic motif GDAY.

Authors: Kailash N Pandey; Huong T Nguyen; Renu Garg; Madan L Khurana; Jude Fink
Journal: Biochem J Date: 2005-05-15 Impact factor: 3.857

10. Elevated brain natriuretic peptide level in patients undergoing atrial fibrillation ablation: is it a predictor of failed ablation or a mere function of atrial rhythm and rate at a point in time?

Authors: Jayasree Pillarisetti; Namratha Reddy; Mazda Biria; Kay Ryschon; Darbhamulla Nagarajan; Caroline Murray; Donita Atkins; Sudharani Bommana; Madhu Yeruva Reddy; Luigi DiBiase; Rhea Pimentel; Loren Berenbom; Buddhadeb Dawn; Andrea Natale; Dhanunjaya Lakkireddy
Journal: J Interv Card Electrophysiol Date: 2014-05-08 Impact factor: 1.900